Screener
Apogee Therapeutics, Inc. APGE Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Other income, net: | ||
| Interest income, net | 8,740 | 7,840 |
| Total other income, net | 8,740 | 7,840 |
| Net loss before taxes | (74,032) | (55,256) |
| Provision for income taxes | (79) | (83) |
| Net loss after taxes | $(74,111) | $(55,339) |
| Net loss per share, basic and diluted | $(1.06) | $(0.95) |
| Weighted-average common shares outstanding, basic and diluted | 69,668,439 | 58,195,272 |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s shares (diluted)?
- Apogee Therapeutics, Inc. (APGE) reported shares (diluted) of 69.7M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Apogee Therapeutics, Inc.'s shares (diluted) increased by 19.7% year-over-year, from 58.2M to 69.7M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s shares (diluted)?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s shares (diluted) has grown at a 76.0% compound annual growth rate (CAGR), from 76.2M to 236.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Apogee Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude